CALL TO ACTION

When choosing nutriiton for VLBW babies complications have costA 100% human milk-based diet can increase survival1 and reduce the overall cost of care for very low birth weight (VLBW) infants under 1250 g.2

Download the resource to learn how Prolacta Bioscience’s line of products help maintain an exclusive human milk diet and decrease costly complications associated with the intake of cow milk-based products.2

Download >>

 

Complete the form on the right to speak with a Prolacta Bioscience representative for a customized economic impact analysis.

 

Request A Custom Value Analysis
CALL TO ACTION

NOTE: Product used in these studies was named Prolact+ H2MF®. The formulation of Prolact+ H2MF ® and HumavantTM HMF is the same. Prolact+ H2MF® is the trade name in North America, and HumavantTM HMF is the trade name outside North America.

Important notice: The Humavant™ product family, except for Humavant™ HM, is considered food for special medical purposes for the dietary management of preterm infants (in Germany, Humavant™ HM is also a food for special medical purposes; it is classified as food in all other European countries). Humavant™ products are not suitable as the sole source of nutrition. Infants may require additional vitamins and iron added separately from the product. Humavant™ products should only be used under medical supervision and are not suitable for parenteral use.

REFERENCES: 1. Abrams SA, Schanler RJ, Lee ML, Rechtman DJ. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med. 2014;9(6):281-285. 2. Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk–based diet. Breastfeed Med. 2016;11(2):70-74. 
© 2025 Prolacta Bioscience